Rise in the aging population worldwide will boost market growth; increasing incidences of age-related ailments such as liver, kidney, and heart are the major factors influencing market growth.
Market Size – USD 497.8 Million in 2018, Market Growth - CAGR of 6.1%, Market Trends –
The expanding use of blood cell analyzers in diagnosing blood transfusion-transmitted infections globally is fuelling the market growth.
The global Hemolysis Agent for Blood Cell Analyzer Market is estimated to reach USD 810.8 Million by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing number of age-related ailments such as liver, kidney, and heart along with an increase in the aging population worldwide. Lead poisoning and sickle cell disease are the reason for increased clinical testing in labs in various regions, which leads to the predominance of blood-related disorders such as hereditary spherocytosis, identification of abnormal hemoglobin’s, cytochemistries on blood and bone marrow, and chronic granulomatous disease. These factors are further expected to drive the market.
Hemolysis agent for blood cell analyzer are frequently used in the determination of the health condition of a person by examining fluid body samples like blood and urine. The enhanced preference for preventive healthcare has encouraged the demand for early detection and treatment of age-related health conditions, which in turn, will increase the growth of hemolysis agent for blood cell analyzers market in the forecast period.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-hemolysis-agent-for-blood-cell-analyzer-market
Further key findings from the report suggest
- The expanding use of blood cell analyzers in diagnosing blood transfusion-transmitted infections globally is a crucial factor emphasizing the market. Various instances of blood donations in some emerging and developed countries is a leading trend bolstering the demand for the market. Also, the widely emerging application of blood cell analyzers in the evaluation of cardiovascular diseases and the frequency of bone marrow disorders are key trends boosting the market.
- Less than 500 ml market of the product segment accounts for the largest market share of 38.92% of the market in 2018, this is mainly due to the vital role played by the analyzers to detect, diagnose, and provide useful data for further studies, regarding different ailments.
- North America is valued at USD 111.0 million in 2018 and is estimated to reach USD 181.6 million by 2026. Several emerging and leading players are launching comprehensive and advanced solutions with new applications for different clinical settings, with a move to consolidate their shares in various regions
- Key participants include Sysmex Corporation, Abbott Laboratories, Prokan Electronics Inc., MultiSciences, Biotech, Jinan bolai, Labnovation technologies, Boule Diagnostics AB, DIRUI Industrial, PeproTech (BioGems) and Suzhou Coming.
For the purpose of this report, Reports and Data have segmented global Hemolysis Agent for Blood Cell Analyzer Market on the basis of Product Type, Application, End Users and region:
- Product Type Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Less than 500 ml
- 500-2000 ml
- 2000 ml
- End User Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Hospitals
- Pharmaceutical companies
- Diagnostic centers
- Bio technology companies
- Application Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026)
- Clinical
- Analytical research
- Others
Request
For Free PDF Sample Of This Research Report At:
- Regional Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2016-2026)
- North America
- U.S.
- Europe
- Germany
- UK
- Asia Pacific
- China
- India
- South-east Asia
- Latin America
- Brazil
- MEA
- North America
No comments:
Post a Comment